The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anavasi Diagnostics, Concept Medical, Hyperfine.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alcon, Astrazeneca, Bigfoot Biomedical, Cleveland Diagnostics, Concerto Renal Services, Dexcom, Elekta, Endostream, GI Dynamics, Histosonics, Insulet, J&J, Lensx, Premier Business Inter, Quest, Rockwell Medical, Sophia Genetics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Irras, Lunit.

Med-tech firms raising money in public or private financings, including: Predictmedix, Seqll.

New hires and promotions in the med-tech industry, including: Axogen, Bioaffinity, Brainsway, Diagnamed, Egg Medical, Harbinger Health, Q Medical, Lifemd, Windgap Medical.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Everest, GSK, Phathom.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aeon, Aristea, Astex, Biodelivery, Corcept, Eli Lilly, Hillstream, Hookipa, IABL, Lobe, Nantpharma, Novavax, Nurexone, Roche, Sanofi, Scilex, Sorrento,Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Basking, Blueprint, Essex, Galapagos, Genentech, Heartseed, Incyte, Kalvista, Kintor, Leo, Novo Nordisk, Pfizer, Pharmazz, Phio, Roche, Vaxxas, Vivacelle.